作者:
James,N.D. [1]
;
Sydes,M.R. [2]
;
Mason,M.D. [3]
;
Clarke,N.W. [4]
;
Anderson,J. [5]
;
Dearnaley,D.P. [6]
;
Dwyer,J. [7]
;
Jovic,G. [8]
;
Ritchie,A.W.S. [9]
;
Russell,J.M. [10]
;
Sanders,K. [11]
;
Thalmann,G.N. [12]
;
Bertelli,G. [13]
;
Birtle,A.J. [14]
;
O'Sullivan,J.M. [15]
;
Protheroe,A. ;
Sheehan,D. ;
Srihari,N. ;
Parmar,M.K.B.
作者单位:
Medical Research Council Clinical Trials Unit, London, United Kingdom
[1]
Shrewsbury and Telford Hospital NHS Trust, Shrewsbury, United Kingdom
[2]
Royal Devon and Exeter, Exeter, United Kingdom
[3]
Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, United Kingdom
[4]
Royal Preston Hospital, Preston, United Kingdom, University of Manchester, Manchester, United
[5]
Institute of Cancer Research, Royal Marsden Hospital, Sutton, United Kingdom
[6]
Prostate Cancer Support Federation, Stockport, United Kingdom
[7]
Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom
[8]
Churchill Hospital, Oxford, United Kingdom
[9]
Inselspital, Bern, Switzerland
[10]
School of Medicine, Cardiff University, Cardiff, United Kingdom
[11]
Christie and Salford Royal Hospitals Foundations Trusts, Manchester University, Manchester, United
[12]
Royal Hallamshire Hospital, Sheffield, United Kingdom
[13]
Singleton Hospital, Swansea, United Kingdom
[14]
School of Cancer Sciences, University of Birmingham, Birmingham, United Kingdom
[15]
发布时间
2013-11-20